To verify whether the expression of serum HCP5 was related to tumor dynamic monitoring, we compared serum HCP5 in unpaired samples, including 98 patients with primary gastric cancer, 46 patients with surgical treatment, and 57 patients with tumor recurrence. The gene discussed is HCP5; the disease is gastric cancer.